[go: up one dir, main page]

CL2009000593A1 - Uso del compuesto [2-(6-fluoro-1h-indol-3-ilsulfanil)bencil]metil amina y sus sales para el tratamiento de la mania, trastorno bipolar, depresion, ansiedad, trastorno compulsivo, entre otros. - Google Patents

Uso del compuesto [2-(6-fluoro-1h-indol-3-ilsulfanil)bencil]metil amina y sus sales para el tratamiento de la mania, trastorno bipolar, depresion, ansiedad, trastorno compulsivo, entre otros.

Info

Publication number
CL2009000593A1
CL2009000593A1 CL2009000593A CL2009000593A CL2009000593A1 CL 2009000593 A1 CL2009000593 A1 CL 2009000593A1 CL 2009000593 A CL2009000593 A CL 2009000593A CL 2009000593 A CL2009000593 A CL 2009000593A CL 2009000593 A1 CL2009000593 A1 CL 2009000593A1
Authority
CL
Chile
Prior art keywords
ylsulfanyl
mania
indol
anxiety
fluoro
Prior art date
Application number
CL2009000593A
Other languages
English (en)
Spanish (es)
Inventor
Neil Anderson
Jeffrey Scott Sprouse
Karina Krojer Soby
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of CL2009000593A1 publication Critical patent/CL2009000593A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
CL2009000593A 2008-03-13 2009-03-12 Uso del compuesto [2-(6-fluoro-1h-indol-3-ilsulfanil)bencil]metil amina y sus sales para el tratamiento de la mania, trastorno bipolar, depresion, ansiedad, trastorno compulsivo, entre otros. CL2009000593A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200800382 2008-03-13

Publications (1)

Publication Number Publication Date
CL2009000593A1 true CL2009000593A1 (es) 2010-03-05

Family

ID=40640280

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2009000593A CL2009000593A1 (es) 2008-03-13 2009-03-12 Uso del compuesto [2-(6-fluoro-1h-indol-3-ilsulfanil)bencil]metil amina y sus sales para el tratamiento de la mania, trastorno bipolar, depresion, ansiedad, trastorno compulsivo, entre otros.

Country Status (4)

Country Link
AR (1) AR072449A1 (fr)
CL (1) CL2009000593A1 (fr)
TW (1) TW200938189A (fr)
WO (1) WO2009112541A2 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20080274T3 (en) * 2003-12-23 2008-12-31 H. Lundbeck A/S 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri
AR054394A1 (es) * 2005-06-17 2007-06-20 Lundbeck & Co As H Derivados de 2- (1h-indolilsulfanil)-aril amina
JP2009538117A (ja) * 2006-03-22 2009-11-05 ハー・ルンドベック・アクチエゼルスカベット うつ病を処置するための化合物を同定する方法
CA2664258A1 (fr) * 2006-09-28 2008-04-03 H. Lundbeck A/S [2-(6-flouro-1h-indol-3-ylsulfanyl)benzyl]methyle amine destinee au traitement de troubles affectifs

Also Published As

Publication number Publication date
WO2009112541A3 (fr) 2009-12-10
AR072449A1 (es) 2010-09-01
TW200938189A (en) 2009-09-16
WO2009112541A2 (fr) 2009-09-17

Similar Documents

Publication Publication Date Title
CL2009000316A1 (es) Compuestos derivados de urea de benzomorfanos y sus sales, inhibidores de la enzima 11-beta-hidroxiesteroide deshidrogenasa; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de trastornos metabolicos.
UY34161A (es) 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil) carbamimidoil)pirazina-2-carboxamida, sus usos, y composiciones que la contienen
CY1120741T1 (el) Θεραπεια οζωδους σκληρυνσης
NI201000044A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
ECSP10010390A (es) Compuestos
UY34264A (es) Compuestos de fórmula genérica 4-(8-metoxi-1-(1-metoxipropan-2-il)-2-(tetrahidro-2H-piran-4-il)-1H- imidazo[4,5-c]quinolin-7-il)-3,5-dimetilisoxazol y sus sales.
CO6321189A2 (es) Compuestos de tiazol y oxazol de bencen-sulfonamida
CR20130066A (es) Compuesto heterocíclico y su uso
BRPI0922384A2 (pt) "manipulador de suprimento para equipamento".
CL2015000942A1 (es) Compuestos de benceno sustituido.
CR20110134A (es) Compuestos con anillos espiro-tricíclicos como moduladores de Beta-secretasas y métodos de uso
CL2009000545A1 (es) Uso de un antagonista de c-met y un antagonista de her para el tratamiento de cancer.
UY33276A (es) Compuestos de amino-oxazinas y amino-dihidrotiazina como moduladores de beta-secretasa y métodos de uso
CR11416A (es) Algunos derivados de 2-pirazinona y su uso como inhibidores de elastasa de los neutrofilos
CL2013002664A1 (es) Compuestos derivados heterociclicos de amina; afines a receptores asociados a mina traza taar1; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento o profilaxis de la depresion, ansiedad, parkinson, trastorno bipolar, de hiperactividad con deficit atencional, relacionados con estres, y otros.
CL2008002450A1 (es) Compuestos derivados de fenil-pirrolidin-eter, con actividad antagonista de los receptores nk3; procedimientos para su preparacion; composicion farmaceutica; y el uso de los compuestos en el tratamiento de depresion, dolor, psicosis, entre otras.
EA201200484A1 (ru) Фармацевтическая композиция с действующими веществами - метформином и ситаглиптином или вилдаглиптином
NI201000015A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
MY143269A (en) Use of agomelatine in obtaining medicaments intended for the treatment of generalized anxiety disorder
CY1114880T1 (el) Αγωνιστες mglu2
CL2009001363S1 (es) Pieza para maquina de afeitar.
HN2009003466A (es) Herbicidas novedosos
CR11860A (es) Derivados de dibenzotiazepina y sus usos - 424
CL2008001837A1 (es) Uso de compuestos derivados de cinolin-3-carboxamida en el tratamiento de la esquizofrenia.
CL2009001089A1 (es) Compuestos derivados de indolo[2,1-a][2]benzacepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la hepatitis c.